{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:52:01Z","timestamp":1776408721917,"version":"3.51.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82300226"],"award-info":[{"award-number":["82300226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170223"],"award-info":[{"award-number":["82170223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Hubei Province","award":["2024AFD421"],"award-info":[{"award-number":["2024AFD421"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study reports an adult-onset case of NK cell\u2013predominant chronic active Epstein-Barr virus infection (CAEBV) harboring multiple heterozygous germline variants affecting antiviral immunity. Functional assessments of NK cell cytotoxicity and degranulation in the patient and her family members revealed subclinical immune defects in several relatives, leading to the exclusion of related donors. The patient ultimately underwent a fully HLA-matched unrelated donor hematopoietic stem cell transplantation (MUD-HSCT), achieving early virologic remission and complete donor chimerism. However, the post-transplant course was complicated by severe immune-related adverse events, including acute and chronic graft-versus-host disease (GVHD), thrombotic microangiopathy, viral reactivations, and secondary hemophagocytic lymphohistiocytosis, ultimately resulting in death due to severe pulmonary infection and multi-organ failure. This case underscores the critical role of immunogenetic risk stratification in guiding transplant decisions. Matched unrelated donor transplantation, supported by comprehensive functional and genetic screening, offers curative potential while avoiding the use of immunologically compromised donors. Nevertheless, long-term outcomes in CAEBV depend not only on virologic remission but also on sustained immune reconstitution. In addition, this report reviews precision transplantation strategies that integrate host genetic background, immune function, and viral dynamics, providing a roadmap for the future management of CAEBV.<\/jats:p>","DOI":"10.1007\/s00277-026-06887-4","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:49:22Z","timestamp":1771469362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Avoidance of related donors in CAEBV with germline immune variants: long-termoutcome of matched unrelated donor HSCT - a case report"],"prefix":"10.1007","volume":"105","author":[{"given":"Xinran","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuxia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"1","key":"6887_CR1","doi-asserted-by":"publisher","first-page":"2329136","DOI":"10.1080\/07853890.2024.2329136","volume":"56","author":"J Jin","year":"2024","unstructured":"Jin J, Mao X, Zhang D (2024) A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry. Ann Med 56(1):2329136","journal-title":"Ann Med"},{"key":"6887_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fimmu.2016.00323","volume":"7","author":"O Chijioke","year":"2016","unstructured":"Chijioke O, Landtwing V, M\u00fcnz C (2016) NK cell influence on the outcome of primary Epstein-Barr virus infection. Front Immunol 7:323Chijioke O, Landtwing V, M\u00fcnz C. NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection. Front Immunol. 2016;7:323. Published 2016 Aug 29. doi:10.3389\/fimmu.2016.00323","journal-title":"Front Immunol"},{"issue":"7","key":"6887_CR3","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/infdis\/jiaa232","volume":"222","author":"MK Howe","year":"2020","unstructured":"Howe MK, Dowdell K, Kuehn HS, Li Q, Hart GT, Garabedian D et al (2020) Patients with natural killer (NK) cell chronic active Epstein-Barr virus have immature NK cells and hyperactivation of PI3K\/Akt\/mTOR and STAT1 pathways. J Infect Dis 222(7):1170\u20131179","journal-title":"J Infect Dis"},{"issue":"12","key":"6887_CR4","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1084\/jem.20190678","volume":"216","author":"R Rodriguez","year":"2019","unstructured":"Rodriguez R, Fournier B, Cordeiro DJ, Winter S, Izawa K, Martin E et al (2019) Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells. J Exp Med 216(12):2800\u20132818","journal-title":"J Exp Med"},{"issue":"1","key":"6887_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1182\/blood.2023021074","volume":"143","author":"J Wang","year":"2024","unstructured":"Wang J, Su M, Wei N, Yan H, Zhang J, Gong Y et al (2024) Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells. Blood 143(1):32\u201341","journal-title":"Blood"},{"issue":"5","key":"6887_CR6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s12185-023-03660-5","volume":"118","author":"JI Kawada","year":"2023","unstructured":"Kawada JI, Ito Y, Ohshima K, Yamada M, Kataoka S, Muramatsu H et al (2023) Updated guidelines for chronic active Epstein-Barr virus disease. Int J Hematol 118(5):568\u2013576","journal-title":"Int J Hematol"},{"issue":"2","key":"6887_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1182\/bloodadvances.2021005291","volume":"6","author":"BJ D\u00e1vila Salda\u00f1a","year":"2022","unstructured":"D\u00e1vila Salda\u00f1a BJ, John T, Bonifant C, Buchbinder D, Chandra S, Chandrakasan S et al (2022) High risk of relapsed disease in patients with NK\/T-cell chronic active Epstein-Barr virus disease outside of Asia. Blood Adv 6(2):452\u2013459","journal-title":"Blood Adv"},{"issue":"6","key":"6887_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s12519-021-00470-9","volume":"17","author":"YH Luo","year":"2021","unstructured":"Luo YH, Yang J, Wei A, Zhu GH, Wang B, Zhang R et al (2021) Haploidentical hematopoietic stem cell transplantation for pediatric patients with chronic active Epstein-Barr virus infection: a retrospective analysis of a single center. World J Pediatr 17(6):626\u2013636","journal-title":"World J Pediatr"},{"issue":"1","key":"6887_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s13023-022-02585-2","volume":"17","author":"R Luo","year":"2022","unstructured":"Luo R, Zhang X, Wang Y, Man Q, Gu W, Tian Z et al (2022) Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT. Orphanet J Rare Dis 17(1):422","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"6887_CR10","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s12185-017-2195-3","volume":"105","author":"J Zhang","year":"2017","unstructured":"Zhang J, Wang Y, Wu L, Wang J, Tang R, Li S et al (2017) Application of an improved flow cytometry-based NK cell activity assay in adult hemophagocytic lymphohistiocytosis. Int J Hematol 105(6):828\u2013834","journal-title":"Int J Hematol"},{"issue":"4","key":"6887_CR11","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jaci.2022.11.012","volume":"151","author":"H Luo","year":"2023","unstructured":"Luo H, Liu D, Liu W, Jin J, Bi X, Zhang P et al (2023) Clinical and genetic characterization of Epstein-Barr virus-associated T\/NK-cell lymphoproliferative diseases. J Allergy Clin Immunol 151(4):1096\u20131109","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"6887_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/infdis\/jiy231","volume":"218","author":"A Hoshino","year":"2018","unstructured":"Hoshino A, Takashima T, Yoshida K, Morimoto A, Kawahara Y, Yeh TW et al (2018) Dysregulation of Epstein-Barr virus infection in hypomorphic ZAP70 mutation. J Infect Dis 218(5):825\u2013834","journal-title":"J Infect Dis"},{"key":"6887_CR13","doi-asserted-by":"crossref","unstructured":"Liu X, Sadaoka T, Krogmann T, Cohen JI (2020) Epstein-Barr virus (EBV) tegument protein BGLF2 suppresses type I interferon signaling to promote EBV reactivation. J Virol 94(11):e00258\u201320","DOI":"10.1128\/JVI.00258-20"},{"issue":"25","key":"6887_CR14","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1182\/blood.2023020973","volume":"143","author":"J Kath","year":"2024","unstructured":"Kath J, Franke C, Drosdek V, Du W, Glaser V, Fuster-Garcia C et al (2024) Integration of \u03b6-deficient cars into the CD3\u03b6 gene conveys potent cytotoxicity in T and NK cells. Blood 143(25):2599\u20132611","journal-title":"Blood"},{"issue":"3","key":"6887_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","volume":"4","author":"Y Okuno","year":"2019","unstructured":"Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T et al (2019) Defective Epstein-Barr virus in chronic active infection and haematological malignancy. Nat Microbiol 4(3):404\u2013413","journal-title":"Nat Microbiol"},{"key":"6887_CR16","doi-asserted-by":"publisher","first-page":"1155883","DOI":"10.3389\/fimmu.2023.1155883","volume":"14","author":"C Mongellaz","year":"2023","unstructured":"Mongellaz C, Vicente R, Noroski LM, Noraz N, Courgnaud V, Chinen J et al (2023) Combined immunodeficiency caused by pathogenic variants in the ZAP70 C-terminal SH2 domain. Front Immunol 14:1155883","journal-title":"Front Immunol"},{"issue":"1","key":"6887_CR17","doi-asserted-by":"publisher","first-page":"e13170","DOI":"10.1111\/sji.13170","volume":"96","author":"C Dexiu","year":"2022","unstructured":"Dexiu C, Xianying L, Yingchun H, Jiafu L (2022) Advances in CD247. Scand J Immunol 96(1):e13170","journal-title":"Scand J Immunol"},{"issue":"4","key":"6887_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","volume":"36","author":"GR Stark","year":"2012","unstructured":"Stark GR, Darnell JE (2012) Jr. The JAK-STAT pathway at Twenty. Immunity 36(4):503\u2013514","journal-title":"Immunity"},{"issue":"2","key":"6887_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1084\/jem.183.2.611","volume":"183","author":"D Qian","year":"1996","unstructured":"Qian D, Mollenauer MN, Weiss A (1996) Dominant-negative zeta-associated protein 70 inhibits T cell antigen receptor signaling. J Exp Med 183(2):611\u2013620","journal-title":"J Exp Med"},{"issue":"50","key":"6887_CR20","doi-asserted-by":"publisher","first-page":"39466","DOI":"10.1074\/jbc.M003626200","volume":"275","author":"A Kusch","year":"2000","unstructured":"Kusch A, Tkachuk S, Haller H, Dietz R, Gulba DC, Lipp M et al (2000) Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction. J Biol Chem 275(50):39466\u201339473","journal-title":"J Biol Chem"},{"issue":"11","key":"6887_CR21","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.bbmt.2014.07.003","volume":"20","author":"R Reshef","year":"2014","unstructured":"Reshef R, Hexner EO, Loren AW, Frey NV, Stadtmauer EA, Luger SM et al (2014) Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning. Biol Blood Marrow Transpl 20(11):1758\u20131766","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"6887_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3324\/haematol.10751","volume":"92","author":"E Juvonen","year":"2007","unstructured":"Juvonen E, Aalto S, Tarkkanen J, Volin L, Hedman K, Ruutu T (2007) Retrospective evaluation of serum epstein barr virus DNA levels in 406 allogeneic stem cell transplant patients. Haematologica 92(6):819\u2013825","journal-title":"Haematologica"},{"issue":"6","key":"6887_CR23","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41409-020-01193-7","volume":"56","author":"N Wei","year":"2021","unstructured":"Wei N, Wang Y, Wang J, Wu L, Wang Z (2021) Characteristics of Epstein-Barr virus reactivation after allogeneic Haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab. Bone Marrow Transpl 56(6):1449\u20131451","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"6887_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S et al (2012) EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 119(3):673\u2013686","journal-title":"Blood"},{"issue":"6","key":"6887_CR25","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ajh.26544","volume":"97","author":"M Yamamoto","year":"2022","unstructured":"Yamamoto M, Sato M, Onishi Y, Sasahara Y, Sano H, Masuko M et al (2022) Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan. Am J Hematol 97(6):780\u2013790","journal-title":"Am J Hematol"},{"issue":"10","key":"6887_CR26","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1086\/587671","volume":"46","author":"K Gotoh","year":"2008","unstructured":"Gotoh K, Ito Y, Shibata-Watanabe Y, Kawada J, Takahashi Y, Yagasaki H et al (2008) Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis 46(10):1525\u20131534","journal-title":"Clin Infect Dis"},{"issue":"3","key":"6887_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4161\/rna.4.3.5206","volume":"4","author":"N Motsch","year":"2007","unstructured":"Motsch N, Pfuhl T, Mrazek J, Barth S, Gr\u00e4sser FA (2007) Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular MicroRNA miR-146a. RNA Biol 4(3):131\u2013137","journal-title":"RNA Biol"},{"key":"6887_CR28","doi-asserted-by":"crossref","unstructured":"Good DJ (2023) Non-coding RNAs in human health and diseases. Genes (Basel) 14(7):1429","DOI":"10.3390\/genes14071429"},{"key":"6887_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fped.2016.00107","volume":"4","author":"G Giardino","year":"2016","unstructured":"Giardino G, Gallo V, Prencipe R, Gaudino G, Romano R, De Cataldis M et al (2016) Unbalanced immune system: immunodeficiencies and autoimmunity. Front Pediatr 4:107","journal-title":"Front Pediatr"},{"issue":"4","key":"6887_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1568-1637(03)00030-8","volume":"2","author":"M Mishto","year":"2003","unstructured":"Mishto M, Santoro A, Bellavista E, Bonaf\u00e9 M, Monti D, Franceschi C (2003) Immunoproteasomes and Immunosenescence. Ageing Res Rev 2(4):419\u2013432","journal-title":"Ageing Res Rev"},{"issue":"4","key":"6887_CR31","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1093\/infdis\/jiaf067","volume":"232","author":"SS Jackson","year":"2025","unstructured":"Jackson SS, Francis J, Pfeiffer RM, Proietti C, Coghill AE, Yu KJ et al (2025) Sex differences in Anti-Epstein-Barr virus antibody responses. J Infect Dis 232(4):e671\u2013e675","journal-title":"J Infect Dis"},{"issue":"1","key":"6887_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/INF.0000000000003738","volume":"42","author":"W Ou","year":"2023","unstructured":"Ou W, Zhao Y, Wei A, Ma H, Zhang L, Lian H et al (2023) Chronic active Epstein-Barr virus infection with central nervous system involvement in children: A clinical study of 22 cases. Pediatr Infect Dis J 42(1):20\u201326","journal-title":"Pediatr Infect Dis J"},{"key":"6887_CR33","doi-asserted-by":"publisher","first-page":"710400","DOI":"10.3389\/fphar.2021.710400","volume":"12","author":"Y Song","year":"2021","unstructured":"Song Y, Wang J, Wang Y, Wang Z (2021) Ruxolitinib in patients with chronic active Epstein-Barr virus infection: A Retrospective, Single-Center study. Front Pharmacol 12:710400","journal-title":"Front Pharmacol"},{"issue":"22","key":"6887_CR34","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM et al (2011) Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the united States. Blood 117(22):5835\u20135849","journal-title":"Blood"},{"key":"6887_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fped.2019.00183","volume":"7","author":"M Ishimura","year":"2019","unstructured":"Ishimura M, Eguchi K, Shiraishi A, Sonoda M, Azuma Y, Yamamoto H et al (2019) Systemic Epstein-Barr Virus-Positive T\/NK lymphoproliferative diseases with SH2D1A\/XIAP hypomorphic gene variants. Front Pediatr 7:183","journal-title":"Front Pediatr"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06887-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06887-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06887-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:59:58Z","timestamp":1776405598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06887-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6887"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06887-4","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (Approval No. 2019S949).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent for publication of the patient\u2019s clinical details and any accompanying images was obtained from the patient\u2019s relative. A copy of the written consent form is provided in Related files","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}